Plant ID: NPO28122
Plant Latin Name: Senecio chionophilus
Taxonomy Genus: Senecio
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
ADORA3; | |
TSHR; | |
PTPN1; | |
BLM; | |
GRIA4; GRIK2; GRIA1; GRIK3; GRIK5; GRIK1; | |
SMN1;SMN2; | |
LMNA; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Ionotropic glutamate receptor | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | P48058 | CHEMBL3190 |
Ionotropic glutamate receptor | GRIK2 | Glutamate receptor ionotropic kainate 2 | Q13002 | CHEMBL3683 |
Ionotropic glutamate receptor | GRIA1 | Glutamate receptor ionotropic, AMPA 1 | P42261 | CHEMBL2009 |
Ionotropic glutamate receptor | GRIK3 | Glutamate receptor ionotropic kainate 3 | Q13003 | CHEMBL3684 |
Ionotropic glutamate receptor | GRIK5 | Glutamate receptor ionotropic kainate 5 | Q16478 | CHEMBL2675 |
Ionotropic glutamate receptor | GRIK1 | Glutamate receptor ionotropic kainate 1 | P39086 | CHEMBL1918 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Small molecule receptor (family A GPCR) | ADORA3 | Adenosine A3 receptor | P0DMS8 | CHEMBL256 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005215; transporter activity | GO:0015277; kainate selective glutamate receptor activity | 6.163E-13 | 1.491E-09 | GRIK1, GRIK2, GRIK3, GRIK5 |
BP | GO:0023052; signaling | GO:0060079; excitatory postsynaptic potential | 2.798E-12 | 5.540E-09 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
CC | GO:0044464; cell part | GO:0043204; perikaryon | 8.490E-09 | 1.027E-05 | GRIK2, GRIK3, GRIK5, SMN1, SMN2 |
MF | GO:0005215; transporter activity | GO:0008381; mechanosensitive ion channel activity | 3.890E-08 | 3.258E-05 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
CC | GO:0044456; synapse part | GO:0045211; postsynaptic membrane | 1.778E-07 | 1.335E-04 | GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
MF | GO:0005215; transporter activity | GO:0098782; mechanosensitived potassium channel activity | 7.897E-07 | 4.777E-04 | GRIK1, GRIK2, GRIK3, GRIK5 |
CC | GO:0032991; macromolecular complex | GO:0032983; kainate selective glutamate receptor complex | 1.254E-06 | 6.561E-04 | GRIK2, GRIK5 |
MF | Unclassified; | GO:0004872; receptor activity | 1.544E-06 | 7.473E-04 | ADORA3, GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5, TSHR |
MF | GO:0005215; transporter activity | GO:0004971; AMPA glutamate receptor activity | 2.507E-06 | 1.137E-03 | GRIA1, GRIA4 |
CC | GO:0044464; cell part | GO:0043005; neuron projection | 6.386E-06 | 2.528E-03 | GRIA1, GRIA4, GRIK3, GRIK5, SMN1, SMN2 |
CC | GO:0044456; synapse part | GO:0043195; terminal bouton | 8.802E-06 | 3.305E-03 | GRIK2, GRIK3, GRIK5 |
BP | GO:0051179; localization | GO:0034220; ion transmembrane transport | 1.130E-05 | 4.035E-03 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
MF | GO:0005488; binding | GO:0030165; PDZ domain binding | 2.360E-05 | 8.029E-03 | GRIA1, GRIK2, GRIK5 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 2.749E-05 | 9.210E-03 | SMN1, SMN2 |
MF | GO:0005215; transporter activity | GO:0005234; extracellularly glutamate-gated ion channel activity | 6.433E-16 | 7.004E-12 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
BP | GO:0009987; cellular process | GO:0035235; ionotropic glutamate receptor signaling pathway | 5.447E-15 | 3.811E-11 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
BP | GO:0023052; signaling | GO:0051967; negative regulation of synaptic transmission, glutamatergic | 3.788E-05 | 1.115E-02 | GRIK2, GRIK3 |
BP | GO:0032501; multicellular organismal process | GO:0007399; nervous system development | 4.930E-05 | 1.394E-02 | GRIK1, SMN1, SMN2, TSHR |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 1.484E-12 | 3.858E-11 | GRIA1, GRIK5, ADORA3, GRIK3, GRIK1, GRIK2, TSHR, GRIA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04724 | Glutamatergic synapse | 4.988E-11 | 6.484E-10 | GRIA1, GRIK5, GRIK3, GRIK1, GRIK2, GRIA4 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 2.578E-04 | 1.950E-03 | GRIA1, TSHR, GRIA4 |
09160 Human Diseases | 09164 Substance dependence | hsa05033 | Nicotine addiction | 3.000E-04 | 1.950E-03 | GRIA1, GRIA4 |
09160 Human Diseases | 09164 Substance dependence | hsa05031 | Amphetamine addiction | 8.420E-04 | 4.379E-03 | GRIA1, GRIA4 |
09150 Organismal Systems | 09159 Environmental adaptation | hsa04713 | Circadian entrainment | 1.683E-03 | 7.055E-03 | GRIA1, GRIA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04723 | Retrograde endocannabinoid signaling | 1.899E-03 | 7.055E-03 | GRIA1, GRIA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04728 | Dopaminergic synapse | 3.074E-03 | 9.989E-03 | GRIA1, GRIA4 |
09120 Genetic Information Processing | 09122 Translation | hsa03013 | RNA transport | 5.389E-03 | 1.557E-02 | SMN2, SMN1 |
09120 Genetic Information Processing | 09124 Replication and repair | hsa03440 | Homologous recombination | 1.869E-02 | 4.860E-02 | BLM |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Ischemia | I99.8 | ADORA3; |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | GRIK1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Alcohol use disorders | F10.2 | GRIK1; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | ADORA3; |
C00-D49: Neoplasms | Cancer | C00-C96 | ADORA3; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | GRIK1; |
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | GRIK1; |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | ADORA3; |
NA: NA | Hepatitis C virus infection | NA | ADORA3; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | ADORA3; |
I00-I99: Diseases of the circulatory system | Cerebrovascular ischaemia | I61-I63 | ADORA3; |
G00-G99: Diseases of the nervous system G00-G99 | Spinal muscular atrophy | G00-G99 | SMN1;SMN2; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | GRIK1; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | ADORA3; |